Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
HKD | Fiscal Year Ending | | Latest |
(in millions) | Mar-15 | Mar-16 | Mar-17 | Mar-18 | Mar-19 | Mar-20 | Mar-21 | Mar-22 | Mar-23 | Mar-24 | | Sep-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 78 | 47 | 15 | 60 | 271 | 228 | 79 | 77 | 64 | 71 | | 102 |
% Growth | NA | -39.6% | -68.3% | 302.2% | 354.3% | -16.1% | -65.1% | -3.1% | -17.2% | 11.8% | | |
| | | | | | | | | | | | |
Cost of Revenue | (96) | (45) | (9) | (39) | (185) | (172) | (70) | (63) | (48) | (55) | | (79) |
Gross Profit | (19) | 2 | 6 | 21 | 86 | 56 | 9 | 14 | 16 | 16 | | 23 |
% Revenue | -24.0% | 3.4% | 39.3% | 35.3% | 31.7% | 24.4% | 11.6% | 18.3% | 25.4% | 22.3% | | 22.1% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Selling and Marketing | (98) | (48) | (0) | (4) | (22) | (17) | (11) | (24) | (10) | (16) | | (20) |
General and Admin | (40) | (43) | (23) | (19) | (29) | (25) | (19) | (9) | (8) | (12) | | (16) |
Other Inc / (Exp) | 68 | (10) | 5 | (142) | 6 | 0 | (4) | (4) | (1) | 20 | | 26 |
Total Operating Exp | (70) | (102) | (19) | (164) | (45) | (42) | (34) | (36) | (19) | (9) | | (11) |
| | | | | | | | | | | | |
Operating Income | (89) | (100) | (13) | (143) | 41 | 13 | (25) | (22) | (3) | 7 | | 12 |
% Revenue | -114.3% | -213.2% | -85.6% | -239.8% | 14.9% | 5.8% | -31.2% | -28.9% | -4.6% | 9.3% | | 11.5% |
| | | | | | | | | | | | |
Interest Expense | (2) | 0 | 0 | 0 | 0 | 0 | (0) | (0) | (0) | 0 | | 0 |
Pre-tax Income | (91) | (100) | (13) | (143) | 41 | 13 | (25) | (22) | (3) | 7 | | 12 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | (0) | (0) | (2) | (2) | (10) | (2) | (2) | 0 | 1 | 0 | | (0) |
Net Income to Company | (91) | (100) | (14) | (145) | 31 | 11 | (27) | (22) | (1) | 7 | | 12 |
% Margin | -117.1% | -213.3% | -96.9% | -242.9% | 11.4% | 4.8% | -33.5% | -29.1% | -2.3% | 9.6% | | 11.8% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Net Income to Stockholders | (91) | (100) | (14) | (145) | 31 | 11 | (27) | (22) | (1) | 7 | | 12 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
| | | | | | | | | | | | |
Net Income to Common | (91) | (100) | (14) | (145) | 31 | 11 | (27) | (22) | (1) | 7 | | 12 |
% Margin | -117.1% | -213.3% | -96.9% | -242.9% | 11.4% | 4.8% | -33.5% | -29.1% | -2.3% | 9.6% | | 11.8% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | (0.40) | (0.20) | (0.02) | (0.13) | 0.03 | 0.01 | (0.02) | (0.02) | (0.00) | 0.01 | | 0.01 |
Diluted EPS (Continuing Ops) | (0.40) | (0.20) | (0.02) | (0.13) | 0.03 | 0.01 | (0.02) | (0.02) | (0.00) | 0.01 | | 0.01 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 228.48 | 505.54 | 729.49 | 1,103.97 | 1,103.97 | 1,103.97 | 1,103.97 | 1,103.97 | 1,103.97 | 1,103.97 | | 1,103.97 |
WA Diluted Shares Out. | 228.48 | 505.54 | 729.49 | 1,103.97 | 1,103.97 | 1,103.97 | 1,103.97 | 1,103.97 | 1,103.97 | 1,103.97 | | 1,103.97 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | (91) | (100) | (13) | (143) | 41 | 13 | (25) | (22) | (3) | 7 | | 12 |
Addback: Net Interest Expense | 2 | (0) | (0) | (0) | (0) | (0) | 0 | 0 | 0 | (0) | | (0) |
Addback: Other Non Operating Expenses, Total | 10 | 7 | (5) | 1 | 2 | (0) | 1 | 4 | (3) | (22) | | (19) |
Addback: Depreciation & Amortization | 4 | 1 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | | 0 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 9 | 141 | 0 | 0 | 0 | 0 | 0 | 3 | | 3 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | (82) | 4 | (1) | 0 | (8) | 0 | 0 | 0 | 0 | 0 | | (9) |
Addback: Asset Writedown | 5 | 0 | (8) | 0 | 0 | 0 | 3 | 0 | 4 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | (1) | 0 | 0 | 0 | 0 | 0 | (0) | (0) | (0) | 0 | | 0 |
Adjusted EBITDA | (152) | (89) | (17) | (1) | 35 | 14 | (20) | (18) | (1) | (13) | | (14) |
% Margin | -196.0% | -188.9% | -113.6% | -2.0% | 13.0% | 6.0% | -25.6% | -23.3% | -2.2% | -18.0% | | -13.5% |
| | | | | | | | | | | | |
Adjusted EBIT | (156) | (90) | (17) | (2) | 35 | 13 | (21) | (19) | (2) | (13) | | (14) |
% Margin | -201.3% | -191.5% | -116.3% | -2.6% | 12.8% | 5.7% | -26.4% | -24.2% | -3.1% | -18.2% | | -13.6% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | (91) | (100) | (14) | (145) | 31 | 11 | (27) | (22) | (1) | 7 | | 12 |
Addback: Unusual Items | (78) | 4 | 0 | 141 | (8) | 0 | 3 | (0) | 3 | 3 | | (7) |
Less: Tax Benefit of Unusual Items (26%) | 20 | (1) | (0) | (37) | 2 | 0 | (1) | 0 | (1) | (1) | | 2 |
Adjusted Net Income | (149) | (97) | (14) | (41) | 25 | 11 | (25) | (22) | 1 | 9 | | 7 |
% Margin | -191.4% | -207.5% | -96.4% | -68.0% | 9.3% | 4.8% | -31.2% | -29.2% | 1.8% | 12.2% | | 7.0% |